2016 Global Survey on Clinical Next-Generation Sequencing
2016 Global Survey on Clinical Next-Generation Sequencing
Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications
09-Jan-2017
North America
Description
The primary goal of this research is to analyze the current and future adoption plans of Next-Generation Sequencing (NGS) for clinical applications. The survey seeks to collect the following key information:
• Outsourcing needs and clinical NGS service providers
• Current and future interest areas of clinical NGS
• Genetic elements of interest
• Purchase patterns for instruments and reagents
• Predominantly used clinical methods (e.g., chip sequencing, whole exome)
• Perspectives of NGS used as complement or replacement for current methods
• Platforms used for NGS clinical data interpretation
• Predominantly cited instruments for clinical use
• Familiarity with clinical NGS service providers
• Factors promoting adoption
• Factors limiting adoption
• Best practices from labs—direct quotes from lab managers
Research Methodology
Lab managers of clinical labs were invited to participate in an online survey during August–November 2016. To qualify for survey participation, respondents had to be working in a private or public laboratory, clinical research institution, reference laboratory, academic medical center facility, hospital lab, or diagnostic company that employs NGS for clinical use. Respondents had to be constant users of this technology, belong to the scientific community, and be in a position to authorize purchases. Over 184 respondents qualified for the survey including C-level officers, lab managers, directors, physicians, post docs, and principal investigators that had a direct interference with the clinical NGS community. End users were also evaluated for their ability to authorize purchases or make product recommendations. Respondents indicated a wide range of job titles, such as lab directors, scientists, lab managers, clinicians, pathologists, and lab technicians. In total, about 82% of respondents work in the United States. Nevertheless, this study is considered global because the survey was open to respondents from all countries.
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Key Findings
Research Objectives
Research Methodology
Research Methodology (continued)
Technology Usage and Outsourced Respondents
Respondent Demographics
Respondent Demographics (continued)
Brand Perception of Top 16 Providers
Current and Future Interest Areas for Clinical NGS Testing
Top 7 Preferred Vendors for NGS Clinical Sequencing Services
Areas of Pathogen Clinical Research and Methodology Used
Interest in Pursuing NGS-based Infectious Disease Testing
Current and Future Plans in Infectious Disease Testing
Brand Familiarity for Infectious Disease Testing
Sequencing Methods Used for Testing
Infectious Disease Sequencing Method
Genetic Elements of Interest for NGS Clinical Work
Correlation of Genetic Elements and Clinical Area of Interest
Correlation of Genetic Elements and Sequencing Methods
Instrument and Reagent Purchase Patterns
Instrument and Reagent Purchase Patterns (continued)
Complemented or Replaced Instruments in Labs
Complementing Instruments/Methods
Instrument Usage—Current and Future Use for Clinical Applications
Analysis of Instruments and Clinical Applications
NGS Data Analysis
Data Analysis for Specific Infectious Disease NGS Application
Current and Future Usage of NGS Informatics Platforms
Factors Promoting Adoption of Clinical NGS
Factors Limiting the Adoption of Clinical NGS
Factors that Helped Overcome Obstacles to Implementing NGS
Legal Disclaimer
Additional Sources of Information
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
North America and Europe Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Related Research
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Divyaa Ravishankar |
Industries | Healthcare |
WIP Number | 9AB9-00-5E-00-00 |
Is Prebook | No |